1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for 'CFS'.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th July 2024 is here.
    Dismiss Notice
  3. Welcome! Read the Core Purpose and Values of our forum.
    Dismiss Notice

Three-year outcomes of post-acute sequelae of COVID-19, 2024, Cai, Xie, Topol, Al-Aly

Discussion in 'Long Covid research' started by SNT Gatchaman, May 30, 2024.

  1. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    5,001
    Location:
    Aotearoa New Zealand
    Three-year outcomes of post-acute sequelae of COVID-19
    Cai, Miao; Xie, Yan; Topol, Eric J.; Al-Aly, Ziyad

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes post-acute sequelae of coronavirus disease 2019 (COVID-19) (PASC) in many organ systems. Risks of these sequelae have been characterized up to 2 years after infection, but longer-term follow-up is limited. Here we built a cohort of 135,161 people with SARS-CoV-2 infection and 5,206,835 controls from the US Department of Veterans Affairs who were followed for 3 years to estimate risks of death and PASC.

    Among non-hospitalized individuals, the increased risk of death was no longer present after the first year of infection, and risk of incident PASC declined over the 3 years but still contributed 9.6 (95% confidence interval (CI): 0.4–18.7) disability-adjusted life years (DALYs) per 1,000 persons in the third year. Among hospitalized individuals, risk of death declined but remained significantly elevated in the third year after infection (incidence rate ratio: 1.29 (95% CI: 1.19–1.40)). Risk of incident PASC declined over the 3 years, but substantial residual risk remained in the third year, leading to 90.0 (95% CI: 55.2–124.8) DALYs per 1,000 persons.

    Altogether, our findings show reduction of risks over time, but the burden of mortality and health loss remains in the third year among hospitalized individuals.

    Link | PDF (Nature Medicine) [Open Access]
     
    SNT Gatchaman, May 30, 2024
    #1
    Deanne NZ, Mij, rvallee and 4 others like this.
  2. Hutan

    Hutan Moderator Staff Member

    Messages:
    27,980
    Location:
    Aotearoa New Zealand
    The data is surely going to be messy, with many people in the control group having Covid-19, and many people in both groups having multiple infections.

    Compared to the control group without infection, people with COVID-19 who were not hospitalized during the acute phase of the disease were at an increased risk of death (incidence rate ratio (IRR): 1.58, 95% confidence interval (CI): 1.53–1.62; excess burden per 1,000 persons: 16.20, 95% CI: 14.90–17.51; Fig. 1a) during the first year after SARS-CoV-2 infection but not in the second year (IRR: 0.97, 95% CI: 0.94–1.00; excess burden per 1,000 persons: −0.91, 95% CI: −2.20 to 0.38) and third year (IRR: 1.01, 95% CI: 0.97–1.04; excess burden per 1,000 persons: 0.22, 95% CI: −1.14 to 1.58) after the infection.

    Excess mortality relative to controls in the three years (years on x axis). Red is the hospitalised group, blue is the unhospitalised group.

    Screen Shot 2024-05-30 at 10.45.26 pm.png

    Incidence of a range of symptom types relative to controls - for non-hospitalised group

    Screen Shot 2024-05-30 at 10.50.32 pm.png

    Fig 2 has a very detailed break down of symptoms that is worth look, with incidence rate ratios.

    Some of the "symptoms", such as 'Nicotine use disorder" which I assume is largely smoking, might actually be a contributor to the person ending up hospitalised with Covid-19. So they are more like a risk factor that is present at a higher rate than in the controls. So, far, while the symptoms are called 'post-acute sequelae' I haven't seen any analysis of symptoms that only arose after the infection.

    Years are the three columns - 1,2,3
    The top row is non-hospitalised
    Bottom row is hospitalised

    Screen Shot 2024-05-30 at 11.03.52 pm.png
    Screen Shot 2024-05-30 at 11.05.25 pm.png
     
    Hutan, May 30, 2024
    #2
    Peter Trewhitt, Deanne NZ and EndME like this.
  3. Dakota15

    Dakota15 Senior Member (Voting Rights)

    Messages:
    491
    Fortune: 'COVID can cause new health problems to appear years after infection, according to a study of more than 130,000 patients’

    'For these and other reasons, researchers have led the charge to accelerate the pace of trials for long COVID treatments..’

    'Researchers hope that this latest study will again focus attention on a disease with a long tail and an unknowable future, and perhaps prod the National Institutes of Health to take a bigger swing at the issue.’

    “We need to be much bolder and much more ambitious with our trials,” Al-Aly says. “At the glacial pace that they’re going, we’re unlikely to get any definitive answers for decades to come.”
     
    Dakota15, May 30, 2024
    #3
    Dolphin, Binkie4, Hutan and 6 others like this.
  4. ME/CFS Skeptic

    ME/CFS Skeptic Senior Member (Voting Rights)

    Messages:
    3,723
    Location:
    Belgium
    They used a veterans database where only 10% of participants were women. Long Covid mostly affects women so probably not an ideal cohort to test long-term sequelae.
     
    ME/CFS Skeptic, May 31, 2024
    #4
    Dolphin, Binkie4, Chezboo and 9 others like this.

Share This Page